{"slug":"what-are-peptides-nerve-damage","verification":{"valid":true,"entries":2,"head":"75ccb025ef1fbd7e37879111a176f2671877c71d23e6b838b950dbc89de1d96b"},"energy":{"passes":2,"tokens_in":32964,"tokens_out":3065,"tokens_total":36029,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"75ccb025ef1fbd7e37879111a176f2671877c71d23e6b838b950dbc89de1d96b"},"provenance":[{"ts":"2026-06-29T21:53:48.419Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: What Are Peptides for Nerve Damage\nSlug: what-are-peptides-nerve-damage\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\",\"section_headings\":[\"What's breaking down\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide essay.\",\"Each Why section must use if-then steps from peptide_chains / drug_chains.\",\"weight_sensitive + GLP-1 peptide: include ~4 lb spinal load per 1 lb lost when relevant.\",\"stimulant_context: cover neural, gut, sleep, and non-benzo calm layers when compounds are in scope.\",\"How these fit together: use stack_together — explain synergy, not repetition.\"]}","response":"{\n  \"slug\": \"what-are-peptides-nerve-damage\",\n  \"title\": \"What Are Peptides for Nerve Damage\",\n  \"body\": \"## What's breaking down\\nNerve damage occurs when axons break down faster than they can regrow. Myelin sheaths degrade. Inflammation persists. Blood supply to nerves drops. Mitochondria in neurons malfunction and fission increases. These layers compound: an initial injury triggers swelling that squeezes axons, cuts off nutrients, and slows repair signals. Without intervention that targets regeneration pathways, the imbalance continues and symptoms like pain, numbness, or weakness remain.\\n\\n## How these fit together\\nPeptides studied for nerve damage often act on separate but linked layers. Some support axonal regrowth and myelination. Others reduce local inflammation or protect mitochondria. A few modulate pain signaling directly. When multiple compounds are considered together, their actions map to different parts of the repair process rather than overlapping on the same step.\\n\\n## What the evidence actually shows\\nRat studies of BPC-157 after sciatic nerve transection showed faster axonal regeneration, thicker myelin, more myelinated fibers, better electromyography readings, and improved walking scores compared with controls (preclinical, source s11). A 2021 rat study found BPC-157 improved outcomes after spinal cord compression across acute to chronic phases (preclinical, source s12). Human data for BPC-157 in nerve injury remain absent from published randomized trials.\\n\\nARA 290, tested in a randomized trial of sarcoidosis patients with small fiber neuropathy, produced greater improvement in symptom scores versus placebo at four weeks with no major safety signals (human, source s2). Self-assembling peptide hydrogels filled nerve conduits in rat sciatic models and supported axon and Schwann cell organization (preclinical, source s23). C-peptide replacement in diabetic rat models prevented C-fiber pathology and improved nerve function (preclinical, source s","tokens_in":32964,"tokens_out":3065,"cost":0,"prev":"genesis","hash":"8d6d9cbc2720509f7cafc3a5a65d34bb72c2887fadded38f7e1a6f3981935af4"},{"ts":"2026-07-17T02:43:33.268Z","model":"owner","action":"voxel_divide","prompt":"","input":"what-are-peptides-nerve-damage","response":"18 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"8d6d9cbc2720509f7cafc3a5a65d34bb72c2887fadded38f7e1a6f3981935af4","hash":"75ccb025ef1fbd7e37879111a176f2671877c71d23e6b838b950dbc89de1d96b"}]}